Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-024353

Director bought 186 shares at an average $4.48 ($833)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2025-04-01 Purchase 10b5-1 +8 $4.24 $34 42,822 D
Jones James Director 2025-04-02 Purchase 10b5-1 +8 $4.39 $35 42,830 D
Jones James Director 2025-04-03 Purchase 10b5-1 +8 $4.21 $34 42,838 D
Jones James Director 2025-04-04 Purchase 10b5-1 +8 $4.23 $34 42,846 D
Jones James Director 2025-04-07 Purchase 10b5-1 +8 $4.19 $34 42,854 D
Jones James Director 2025-04-08 Purchase 10b5-1 +8 $4.14 $33 42,862 D
Jones James Director 2025-04-09 Purchase 10b5-1 +8 $4.09 $33 42,870 D
Jones James Director 2025-04-10 Purchase 10b5-1 +8 $4.01 $32 42,878 D
Jones James Director 2025-04-11 Purchase 10b5-1 +8 $4.02 $32 42,886 D
Jones James Director 2025-04-14 Purchase 10b5-1 +10 $4.03 $40 42,896 D
Jones James Director 2025-04-15 Purchase 10b5-1 +10 $4.14 $41 42,906 D
Jones James Director 2025-04-16 Purchase 10b5-1 +10 $4.23 $42 42,916 D
Jones James Director 2025-04-17 Purchase 10b5-1 +10 $4.61 $46 42,926 D
Jones James Director 2025-04-21 Purchase 10b5-1 +10 $4.79 $48 42,936 D
Jones James Director 2025-04-22 Purchase 10b5-1 +10 $4.74 $47 42,946 D
Jones James Director 2025-04-23 Purchase 10b5-1 +10 $5.01 $50 42,956 D
Jones James Director 2025-04-24 Purchase 10b5-1 +10 $5.12 $51 42,966 D
Jones James Director 2025-04-25 Purchase 10b5-1 +10 $4.94 $49 42,976 D
Jones James Director 2025-04-28 Purchase 10b5-1 +8 $4.91 $39 42,984 D
Jones James Director 2025-04-29 Purchase 10b5-1 +8 $4.93 $39 42,992 D
Jones James Director 2025-04-30 Purchase 10b5-1 +8 $4.79 $38 43,000 D
Open-market purchases · 186 sh · avg $4.48 · $833
Loading xslF345X05/wk-form4_1746824660.xml…